Liminatus Pharma, Inc. (LIMN)
3.76
+0.07
(+1.90%)
USD |
NASDAQ |
Oct 09, 16:00
3.78
+0.02
(+0.53%)
After-Hours: 20:00
Liminatus Pharma Shareholders Equity (Quarterly) : 0.3006M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3006M |
| March 31, 2026 | -0.1326M |
| December 31, 2025 | -9.815M |
| September 30, 2025 | -1.646M |
| June 30, 2025 | -8.807M |
| March 31, 2025 | -0.001M |
| December 31, 2024 | -19.34M |
| September 30, 2024 | -14.26M |
| June 30, 2024 | -13.07M |
| March 31, 2024 | -12.53M |
| December 31, 2023 | -10.69M |
| September 30, 2023 | -10.21M |
| Date | Value |
|---|---|
| June 30, 2023 | 0.58M |
| March 31, 2023 | 0.3405M |
| December 31, 2022 | 1.294M |
| September 30, 2022 | 265.27M |
| June 30, 2022 | 262.54M |
| March 31, 2022 | 258.68M |
| December 31, 2021 | 254.87M |
| September 30, 2021 | 255.14M |
| June 30, 2021 | 248.37M |
| March 31, 2021 | 248.54M |
| December 31, 2020 | 0.0237M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.404M |
| Total Liabilities (Quarterly) | 3.103M |
| Debt to Equity Ratio | 4.799 |
| Current Ratio | 1.116 |
| Net Debt Paydown Yield | -233.3% |